The (11;22) chromosomal translocation found in Ewing's sarcoma and rel
ated tumors fuses the amino terminus of the EWS protein to the DNA-bin
ding domain of the FLI-1 transcription factor. In contrast to normal F
LI-1, the EWS/FLI-1 fusion transforms NIH3T3 cells and this activity r
equires both EWS and FLI-1 sequences. Reporter gene assays showed that
the portion of EWS fused to FLI-1 encodes a strong transcriptional ac
tivation domain. To determine whether this function is necessary for t
ransformation by EWS/FLI-1, deletion analysis of EWS was performed. We
found that the EWS domain could be functionally subdivided into two r
egions: (i) an amino terminal domain (domain A) which transforms effic
iently when fused to FLI-1 but has little transactivation activity in
a model system and (ii) a distal region (domain B) which transactivate
s efficiently but transforms less efficiently when fused to FLI-1. Rep
lacement of the EWS domain with known heterologous transcriptional act
ivation domains yielded chimeric FLI-1 fusions that in some instances
could transform NM3T3 cells. Finally we demonstrate that EWS/FLI-1 and
related FLI-1 chimeras are able to cooperate,vith another transcripti
on factor to activate a model reporter gene. These results further dem
onstrate that EWS/FLI-1 is an aberrant transcription factor and sugges
t that the EWS domain mediates important protein-protein interactions
with other factors resulting in the transcriptional modulation of targ
et genes.